These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28933574)

  • 21. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
    Carmina E; Fruzzetti F; Lobo RA
    Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women.
    Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS
    J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years.
    Bili H; Laven J; Imani B; Eijkemans MJ; Fauser BC
    Eur J Endocrinol; 2001 Dec; 145(6):749-55. PubMed ID: 11720900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study.
    Malini NA; Roy George K
    Gen Comp Endocrinol; 2018 May; 260():51-57. PubMed ID: 29273352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Kisspeptin levels in unexplained infertility, polycystic ovary syndrome, and male factor infertility.
    Kaya C; Alay İ; Babayeva G; Gedikbaşı A; Ertaş Kaya S; Ekin M; Yaşar L
    Gynecol Endocrinol; 2019 Mar; 35(3):228-232. PubMed ID: 30328739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis.
    Pratama G; Wiweko B; Asmarinah ; Widyahening IS; Andraini T; Bayuaji H; Hestiantoro A
    Sci Rep; 2024 Apr; 14(1):8229. PubMed ID: 38589425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women?
    Ersoy AO; Tokmak A; Ozler S; Oztas E; Ersoy E; Celik HT; Erdamar H; Yilmaz N
    Arch Gynecol Obstet; 2016 Aug; 294(2):403-9. PubMed ID: 27071619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is There an Association Between Circulating Kisspeptin Levels and Ovarian Reserve in Women of Reproductive Age?
    Nikolettos K; Vlahos N; Pagonopoulou O; Nikolettos N; Zikopoulos K; Tsikouras P; Kontomanolis E; Damaskos C; Garmpis N; Asimakopoulos B
    In Vivo; 2023; 37(5):2219-2223. PubMed ID: 37652519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS
    BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns.
    Gorkem U; Kucukler FK; Togrul C; Gungor T
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):464-468. PubMed ID: 28419409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.